Humana (HUM) Price to Sales (2009 - 2026)

Humana (HUM) has reported Price to Sales for 18 consecutive years, with 1.17 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales rose 28.56% year-over-year to 1.17 in Q2 2026; TTM through Jun 2026 was 0.33, a 37.09% increase from a year earlier, with the FY2025 full-year figure at 0.24, down 8.35% from the prior year.
• Price to Sales was 1.17 for Q2 2026 at Humana, up from 0.53 in the prior quarter.
• Over five years, Price to Sales peaked at 97.88 in Q4 2022 and troughed at 0.53 in Q1 2026.
• A 5-year average of 6.94 and a median of 1.47 in 2024 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales surged 3408.12% in 2022 and slumped 97.87% in 2023, its largest moves.
• Over 5 years, Price to Sales stood at 97.88 in 2022, then tumbled by 97.87% to 2.09 in 2023, then slumped by 49.8% to 1.05 in 2024, then slipped by 9.34% to 0.95 in 2025, then rose by 22.86% to 1.17 in 2026.
• The last three Price to Sales figures came in at 1.17 (Q2 2026), 0.53 (Q1 2026), and 0.95 (Q4 2025), per Business Quant data.